Therapeutic potential of cis-targeting bispecific antibodies
- 6 August 2024
- journal article
- review article
- Published by Elsevier in Cell Chemical Biology
- Vol. 31 (8) , 1473-1489
Abstract
No abstract availableKeywords
This publication has 150 references indexed in Scilit:
- Bispecific antibodies in cancer therapy: Target selection and regulatory requirementsActa Pharmaceutica Sinica B, 2023
- Emergence of mass spectrometry detergents for membrane proteomicsAnalytical and Bioanalytical Chemistry, 2023
- Cadonilimab: First ApprovalDrugs, 2022
- Faricimab: First ApprovalDrugs, 2022
- Bispecific antibodies targeting dual tumor-associated antigens in cancer therapyJournal of Cancer Research and Clinical Oncology, 2020
- The role of polarisation of circulating tumour cells in cancer metastasisCellular and Molecular Life Sciences, 2019
- A bispecific antibody directly induces lymphoma cell death by simultaneously targeting CD20 and HLA-DRJournal of Cancer Research and Clinical Oncology, 2015
- Linking 3D and 2D binding kinetics of membrane proteins by multiscale simulationsProtein Science, 2014
- A bispecific EpCAM/CD133-targeted toxin is effective against carcinomaTargeted Oncology, 2013
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialInternational Journal of Cancer, 2010